JSPR

Conviction 20HealthcareScan · Thu, Jun 25, 2026

JSPR$0.4427-9.76%

ResistanceSupportVol 14

Vol MA14 597.28K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Jasper Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.jaspertherapeutics.com ↗

Price0.4427

Change-9.76%

Gap-2.98%

Rel volume2.97×

Avg volume838.69K

Avg $ vol430.84K

SMA 200.5207

SMA 500.7643

SMA 2001.49

Price vs 50-42.08%

Price vs 200-70.26%

MA stackbearish

50/200 cross—

Supertrenddown · 0.6692

RSI (14)31

MACD hist0.01

MACD crossbull · 3d

Stoch %K / %D13 / 28

ADX (14)24

+DI / −DI21 / 24

RSI divergence—

MACD divergence—

ATR %+17.03%

ADR %16.01%

52w high6.82

52w low0.4427

From 52w high-93.51%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width89.74%

%B0.33

Donchian pos4.50%

Donchian high0.9240

Donchian low0.4200

AVWAP (52w high)1.83

vs AVWAP high-75.83%

AVWAP (52w low)0.4773

vs AVWAP low-7.24%

OBV trendDown

Chaikin MF (20)-0.35

Today vs 20d2.97×

Avg vol (14d)597.28K

Avg vol (20d)838.69K

Avg $ vol (20d)430.84K

Market cap12.39M

RS 3m (vs SPY)-69.60%

RS 6m (vs SPY)-81.36%

RS line new highNo

Trend template0/8

Technical rank2.1

1 week-6.09%

1 month-51.49%

3 months-59.39%

6 months-76.82%

1 year-92.05%

YTD-75.94%

P/E-0.16

P/B3.65

P/S—

P/FCF—

EPS-3.95

Div yield—

ROE—

ROA-357.82%

Debt/Eq—

Current2.26

EV/EBITDA0.02

Gross margin—

Net margin—

Rev growth—

EPS growth-6.36%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.75M

Revenue—

Net income-1.17M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out28M

Employees22

ListedMon, Sep 27, 2021

Free float22.74M

Float %81.2%

Short interest2.25M

Days to cover9.5d

Short volume51.2%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank2.1 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.02

Support0.4250

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JSPR

All disclosures →

No recent disclosed trades by Congress in JSPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JSPR

No recent insider (Form 4) filings in JSPR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JSPR · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.